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Bisphenol A (BPA), the principal constituent of reusable water bottles, metal cans, and plastic food containers, has
been shown to be involved in human prostate cancer (PCa) cell proliferation. The aim of the present study was to
explore the effect of BPA on PCa cell migration and the pathways involved in these processes. Using the transwell
technique, we clearly show for the first time that the pre-treatment of the cells with BPA (1–10 nM) induces human
PCa cell migration. Using a calcium imaging technique, we show that BPA pre-treatment induces an amplification
of Store-Operated Calcium Entry (SOCE) in LNCaP cells. RT-PCR and Western blot experiments allowed the
identification of the ion channel proteins which are up-regulated by BPA pre-treatments. These include the Orai1
protein, which is known as an important SOCE actor in various cell systems, including human PCa cells. Using a
siRNA strategy, we observed that BPA-induced amplification of SOCE was Orai1-dependent. Interestingly, the
BPA-induced PCa cell migration was suppressed when the calcium entry was impaired by the use of SOCE
inhibitors (SKF96365, BTP2), or when the extracellular calcium was chelated. Taken together, the results presented
here show that BPA induces PCa cells migration via a modulation of the ion channel protein expression involved in
calcium entry and in cancer cell migration. The present data provide novel insights into the molecular mechanisms
involved in the effects of an environmental factor on cancer cells and suggest both the necessity of preventive
measures and the possibility of targeting ion channels in the treatment of PCa cell metastasis.
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Prostate cancerBackground
Prostate cancer (PCa) is the most common non-cutaneous
malignancy diagnosed in men and the metastatic PCa
forms represent the second cause of mortality (Gronberg
2003; Jemal et al. 2009). Early PCa requires androgen to
survive and to proliferate; this dependence is exploited in
the treatment of a disseminated disease, where androgen
ablation is the first line of therapeutic intervention. Al-
though these regimens are initially effective, tumors
ultimately recur due to reactivation of Androgen* Correspondence: morad.roudbaraki@univ-lille1.fr
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in any medium, provided the original work is pReceptor (AR) signalling, causing treatment failure
and patient morbidity. Despite the importance of
understanding androgen action in the prostate, little
is understood about the mechanisms underlying an-
drogen independence, and the means by which the
androgen requirement is bypassed in relapsed tumors.
As such, identifying the factors affecting the efficacy
of androgen deprivation therapy is essential in order
to improve the outcome of PCa treatment and
thereby to increase patient survival.
Accruing evidence indicates that exposure to environ-
mental compounds, “endocrine disrupting compounds”,
or EDCs, may adversely impact human health through
multiple mechanisms, including alterations to the hor-
mone receptor function (Henley and Korach 2006;
Welshons et al. 2003). In humans, a putative link hasis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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EDCs in the environment and rising hormone-dependent
cancer incidence (Huff et al. 1996). Thus, recent inves-
tigations have placed particular emphasis on delineating
the consequence of EDC exposure for various tissues in-
cluding the reproductive tissues.
One such environmental factor is bisphenol A (BPA),
a non-planar plasticizer leached in microgram quanti-
ties from polycarbonate plastics and epoxy resins into
food and water supplies (Welshons et al. 2003). Studies
showed that up to 95% of adults have detectable BPA in
their urine (Calafat et al. 2005), with adult serum con-
centrations reported to range in nanomolar concen-
trations [reviewed by (Welshons et al. 2006). Further,
BPA has been shown to be involved in prostate carcino-
genesis. A recent animal studies showed that perinatal
exposure to BPA at low doses results in increased sensi-
tivity to estrogen as the male animal ages, and to an
increased risk of developing PCa (Ho et al. 2006). At en-
vironmentally relevant levels (1nM), BPA has also been
identified as a mitogen for a subset of PCa cell lines
(Wetherill et al. 2002; Wetherill et al. 2005; Wetherill
et al. 2006), in addition to accelerating tumor growth
after androgen ablation (Wetherill et al. 2006). BPA was
also shown to induce the growth and resistance to
apoptosis of human breast cancer cells, suggesting that
hormone-dependent tissues are affected by this environ-
ment factor (LaPensee et al. 2010; Pupo et al. 2012).
Another aspect of tumor cell evolution is their metas-
tasis, which is the major cause of death from PCa. Inva-
sion of surrounding tissue and vasculature by cancer
cells is an initial step in tumor metastasis. Environmen-
tal factors such as BPA could impact PCa metastasis by
inducing cell migration. However, data on the effects of
BPA on human cancer cell migration are lacking.
Accumulating data show that cell proliferation, apop-
tosis and migration are paralleled by an altered function
and/or expression of ion channels involved in the signal-
ling of fundamental cellular mechanisms (Lang et al.
2005; Prevarskaya et al. 2011). A ubiquitous Ca2+ influx
pathway that is activated by intracellular Ca2+ store de-
pletion is store-operated Ca2+ entry (SOCE), which is
activated through a complex interplay between a Ca2+
channel at the cell membrane, Orai1, and a Ca2+ sensor
located in the endoplasmic reticulum, STIM1 (Courjaret
and Machaca 2012). Recently, a number of known mo-
lecular players in cellular Ca2 homeostasis, including
Orai1, STIM1 and transient receptor potential (TRP)
channels have been implicated in tumor cell migra-
tion and the metastatic cell phenotype (for review see
Prevarskaya et al. 2011). In this context, we previously
showed that TRPC1, TRPV6 and Orai1 are the main
actors in SOCE in human PCa cells LNCaP (Flourakis
et al. 2010; Vanden Abeele et al. 2003a,b).Here, for the first time, we investigated the impact of
BPA on human PCa cell migration and the mechanisms
involved in the effects of BPA in these cells. In the latter
context, we studied the impact of BPA on calcium sig-
nalling, on the expression of ion channels involved in
SOCE and human PCa cell migration in the absence of
androgens.
Results
BPA increases the migration of prostate cancer cells
Previous works have clearly shown that BPA induces cell
proliferation in androgen-dependent human PCa cells
(Wetherill et al. 2005). In addition to cell growth, cancer
metastasis is significantly involved in the progression of
the disease and leads to death. Cancer cell migration
and invasion play very important roles in cancer me-
tastasis. So, we further studied the effects of BPA on
migration and invasion, as well as the related calcium
signalling in androgen-dependent and -independent hu-
man PCa cells. Migration assay using transwell chambers
showed that BPA at low concentrations of 1 and 10 nM
significantly increased the migration of LNCaP cells with
an increase rate of 800% and 900% respectively, after the
cells were treated for 48 h with BPA prior to the migra-
tion assays (Figure 1A and 1B). In these experiments,
when higher concentrations of BPA (100 nM and 1 μM)
were used, the BPA-induced cell migration rate was si-
milar to the one observed with 10 nM (data not shown).
We further studied the mechanisms involved in the
effects of BPA on PCa cells.
Effects of BPA on calcium signalling in prostate
cancer cells
Several studies have shown that an increase in intracel-
lular calcium originating from an extracellular source
greatly promotes the migration of cancer cells (Saidak
et al. 2009; Yang et al. 2009). Yang et al. (2009) clear-
ly showed that store-operated calcium entry channels
(Orai1 and STIM1) are essential for breast tumor cell
migration in vitro and tumor metastasis in mice. In this
context, BPA could induce the activation and/or over-
expression of ion channels proteins involved in calcium
entry and thus promotes the consequent PCa cell mig-
ration. First, we examined the direct effects of BPA on
the free cytosolic calcium concentration. When different
concentrations of BPA were applied to LNCaP cells, an
androgen-dependent PCa cell line (Figure 2A) and to
LNCaP-C4.2 cells, which are a more invasive cell line
derived from LNCaP cells (Figure 3A), no significant
modification of the basal calcium was observed. To de-
termine if BPA can induce a delayed calcium response,
LNCaP cells were exposed to a range of the environ-
mental factor concentrations (1nM, 10 nM, 1 μM and
























Figure 1 BPA induces prostate cancer cells migration. Cell migration was measured via the Transwell chamber assay. (A) Following the 48 h
BPA treatments, LNCaP cells were trypsinized and equal numbers of live cells were plated into inserts and allowed to migrate for 24 h. Cells in
the insert (non-migrated cells) were eliminated by scraping and migrated cells were fixed and their nuclei were stained by Hoechst 33342 dye
(Blue) and examined under fluorescence microscopy. At least ten different fields per condition were examined and cells were then counted.
Experiments were performed in duplicate and repeated at least twice. (B) Relative migration (%) ± S.E. (Bar) is shown for the indicated BPA
concentrations and the control condition (CTL-ST), where the cells were incubated in CS-RPMI alone. *, P < 0.001 relative to CTL condition.
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experiments, we observed no calcium response to the
applications of BPA. These data confirm the absence of
a direct effect of BPA on the activity of the ion channels
in human prostate cancer cells.
We further examined the modification of the calcium
signalling and remodelling of the expression of the ion
channels in PCa cells after a pre-treatment with BPA. To
verify the possible modification of the calcium signalling
in BPA-treated cells, a test, as described in the following
section, was used to compare the rate of calcium entry
in control and in BPA-treated cells.Ca2+ entry, but not Ca2+ release, is increased in
BPA- treated LNCaP cells
We previously showed that the application of the store-
depleting SERCA inhibitor thapsigargin (TG) induces
a calcium mobilization from intracellular stores and
a calcium entry due to SOCE in human PCa cells
(Lallet-Daher et al. 2009).
The two phases of free intracellular calcium concen-
tration ([Ca2+]i) changes were separated using a Ca2+
add-back protocol. The addition of the store-depleting
SERCA inhibitor thapsigargin (TG, 200 nM) in nomi-
nally Ca2+-free solution was followed by rapid, transient
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Figure 2 Effects of BPA on basal calcium and Store-operated Ca2+ (SOC) entry (SOCE) in LNCaP cells. (A) Cells were grown on glass
coverslips and cultured in complete medium and then the direct effects of BPA at different concentrations on [Ca2+]i were studied by calcium
imaging. (B, C, E) Cells grown on glass coverslips and cultured in CS-RPMI alone (CTL), or containing BPA at 1 or 10 nM BPA for 24 h (B) or
48 h (C, E) and then processed by calcium imaging to estimate the amplitude of SOCE. For Ca2+ recording, cells were treated with 200 nM
thapsigargin (TG) in Ca2+-free bath solution (0 Ca2+) and exposed to 2 mM extracellular Ca2+ (2Ca2+) as indicated. Each experiment was repeated
at least 3 times in duplicate in different cell cultures on a field of 25–40 cells and representative experiments performed on 50–80 cells as
mean ± S.E. are presented. A quantification of the SOCE for each experiment is presented in (D) and (F) (mean ± S.E., n = 50–80 cells), *P < 0.01.
The TG application is shown by an arrow and extracellular Ca2+ increases from 0 (0 Ca2+) to 2 mM (2 Ca2+) are marked by horizontal bars.
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(Figure 2B) These increases are due to the mobilization
of Ca2+ from internal stores. A subsequent addition of
Ca2+ to the extracellular bath resulted in a rapid and sus-
tained increase in cytosolic Ca2+ due to SOCE. Analyses
were also performed on both the rate of the TG-induced
calcium mobilization and the amplitude of SOCE in CTL
cells versus those treated with different concentrations ofBPA for 24 and 48 h. In these analyses, the amplitude and
the decay of the calcium mobilization were not signifi-
cantly different between CTL and treated cells (Figure 2B,
2D and 2F). Interestingly, in these experiments, we ob-
served that when the cells were cultured in a steroid-free
medium (CS-RPMI), the amplitude of the SOCE was sig-
nificantly lower (40 to 50%) than that developed in cells
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Figure 3 Effects of BPA on basal calcium and Store-operated Ca2+ (SOC) entry (SOCE) in LNCaP C4.2 cells. (A) Cells were grown on glass
coverslips and cultured in complete medium and then the direct effects of BPA at different concentrations on [Ca2+]i were studied by calcium
imaging. (B) Cells grown on glass coverslips and cultured in CS-RPMI alone (CTL), or containing BPA at 1 nM BPA for 48h and then processed by
calcium imaging to estimate the amplitude of SOCE. For Ca2+ recording, cells were treated with 200 nM thapsigargin (TG) in Ca2+-free bath
solution (0 Ca2+) and exposed to 2 mM extracellular Ca2+ (2 Ca2+) as indicated. Each experiment was repeated at least 3 times in duplicate in
different cell cultures on a field of 25–40 cells and representative experiments performed on 50–80 cells as mean ± S.E. are presented. A
quantification of the SOCE for experiment (B) is presented in (C) (mean ± S.E., n = 50–80 cells), *P < 0.01. The TG application is shown by an arrow
and extracellular Ca2+ increases from 0 (0 Ca2+) to 2 mM (2 Ca2+) are marked by horizontal bars. The graphs represent the mean peak amplitudes
of calcium mobilization and SOCE ± S.E. of at least three independent experiments and are expressed as the percentage above control value.
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in LNCaP treated with BPA for 24, and 48 h. At 24 h
(Figure 2B), the amplitude of the Ca2+ entry (SOCE) was
40 ± 15% higher than that developed in the cells cultured
for the same periods in CS-RPMI alone (CTL). These
effects of BPA reached 85 ± 19% and 122 ± 19% when the
cells were pre-treated for 48 h by BPA 1 nM (Figure 2C
and 2D) and 10 nM (Figure 2E and 2F) respectively. Simi-
lar SOCE amplifications were observed for LNCaP-C4.2, a
more invasive cell line derived from LNCaP cells (Figure 3B
and 3C). These observations suggest that BPA modulates
the expression of the ion channels involved in the SOCE in
human PCa cells. The identification of these ion channels
could allow a schematization of the mechanism by which
BPA modulates these cancer cells migrations.
BPA up-regulated ion channels expression in prostate
cancer cell lines
Our previous studies showed that of several ion chan-
nels, it was mainly the calcium channels (Orai1/STIM1,
TRPV6) and potassium channels (IKCa1, BKCa) that wereinvolved in the generation of the SOCE in human PCa
cells (Flourakis et al. 2010; Lallet-Daher et al. 2009;
Vanden Abeele et al. 2003a,b). Thus, experiments were
designed to explore the impact of a 48 h exposure of the
cells to BPA on the expression of these calcium and po-
tassium channels involved in the SOCE. In the present
study, in order to eliminate the impact of steroids, and
androgens in particular, the experiments were performed
in Phenol red-free RPMI 1640 containing charcoal-
stripped Foetal Calf Serum (FCS) (CS-RPMI or -ST),
a steroid-deprived medium. We have previously shown
that the expression of Orai1 was at least decreased by 90%
in this steroïds-free medium (Flourakis et al. 2010).
As shown in Figure 4, the rate of Orai1 transcript
(Figure 4A) and protein (Figure 4B) was significantly
lower when the cells were incubated in CS-RPMI, sug-
gesting that Orai1 expression is steroid-dependent. Inte-
restingly, when the cells were treated with 0.1 to 10 nM
BPA, the Orai1 protein level was much higher at the
mRNA (Figure 4A) and protein (Figure 4B) levels. Orai1
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Figure 4 Effects of BPA on Orai1 and STIM1 expression in prostate cancer cells. (A), Total RNA was extracted and semi-quantitative RT-PCR
experiments performed to study the expression of Orai1 (406 bp) mRNA using specific primers. β-actin mRNA expression (212 bp) was used as an
internal standard. PCRs were carried out as described in Methods using 40 ng ARN equivalent cDNA from CTL and treated samples. H2O and
samples without reverse transcriptase (not shown) were used as negative controls. Amplified fragments were resolved on 1.5% agarose gel by
electrophoresis and visualized by EtBr staining.M, 1-kb DNA ladder, a molecular weight marker. (B, C, D), Effects of BPA on the ion channels'
protein expression in LNCaP cells. Following the 48 h BPA treatments, total proteins were extracted and 10 μg proteins were analysed on 10%
acrylamide gel (SDS-PAGE), transferred to PVDF membranes. Immuno-blots were then performed as described in Methods for the detection of
Orai1 and STIM1. β-actin expression was used for the loading control of the samples. Experiments were performed at least twice in two
independent cell cultures and representative figures are presented. The fold variation of the Orai1 and STIM1 proteins in different samples
normalized to β-actin expression is shown under the panel. (E), Immunofluorescence studies of the effects of BPA on the expression of Orai1 in
LNCaP. Cells were cultured for 48 h in the complete medium containing steroids (CTL + ST) or in the same medium without steroids (CS-RPMI,
CTL -ST) or in CS-RPMI containing 1 nM BPA. (F), Expression of Orai1 protein in human PCa tissue. PCa tissue Cryosections were processed by
Immunofluorescence for the detection of Orai1. S, Stroma; A, Acinus.
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by Gwack et al. (2007). We have previously shown that
the expression of Orai1 was modulated by the AR path-
ways (Flourakis et al. 2010). In the present work, the
AR agonist (DHT) was used as a positive CTL for the
induction of Orai1 protein expression, as observed by
western-blotting. As shown in Figure 4C, the expression
of Orai1 induced by the activation of the Androgen Re-
ceptor by 1 nM DHT was mimiked by BPA. This would
suggest that the effects of BPA on Orai1 expression
could be at least partly mediated by activation of the AR.
In these experiments, BPA failed to significantly affect
the expression of the Orai1 partner, STIM1 (Figure 4D).
The up-regulation of Orai1 protein by BPA is confirmed
by immunofluorescence studies performed on LNCaP
cells. The incubation of the cells in CS-RPMI (−ST) re-
duced Orai1 staining, whereas the 1 nM BPA treatments
of cells for 48 h induced intense Orai1 protein staining
(Figure 4E). As these experiments on Orai1 proteins
were performed on the LNCaP PCa cell line, we studied
the expression of Orai1 protein in 3 grade 3 human PCa
tissues using immunofluorescence. As shown in Figure 4F,
Orai1 immunostaining was observed in epithelial cells of
the acini, as well as in stromal cells, suggesting a role for
the protein in both the epithelial and stromal cells com-
partments of PCa tissues.
Further experiments dealing with the modulation of
other calcium and potassium channels potentially invol-
ved in SOCE in LNCaP cells showed a clear modification
of their expression in BPA-treated cells. In the same
manner, the expression of the TRPV6 calcium channel
(Figure 5A) and those of BKCa and IKCa1 Ca
2+-activated
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Figure 5 Effects of BPA on the ion channels proteins expression in LN
extracted and 10 μg proteins were analysed on 10% acrylamide gel (SDS-P
performed as described in Methods for the detection of TRPV6 (A), BKCa an
samples. Experiments were performed at least twice in two independent c
of the proteins in different samples normalized to β-actin expression is shoup-regulated potassium channels (BKCa and IKCa1), by hy-
perpolarizing the membrane potential, may be implicated
in the BPA-induced amplification of SOCE, by promoting
significant calcium entry through Orai1 and TRPV6.
Involvement of Orai1 in BPA-induced modification of
calcium signalling
It has previously been shown that Ca2+ influx is essential
for the migration of various cell types, including tumor
cells (Komuro and Rakic 1993; Marks and Maxfield 1990;
Nishiyama et al. 2003; Yang and Huang 2005). In addition,
recent data has clearly shown that Orai1 and STIM1, both
of which involved in store-operated calcium entry, are es-
sential for tumor cell migration in vitro and tumor metas-
tasis in mice (Yang et al. 2009). Thus, the BPA-induced
up-regulation of Orai1 expression might be involved in
the effects of the environmental factor on cell migration.
In this context, we studied the involvement of the Orai1
protein in the effects of BPA on calcium signalling in
LNCaP cells. The cells were treated with Orai1 targeting
siRNA (siOrai1, 20 nM) for 48 h during the BPA treat-
ments of the cells. Then, calcium imaging experiments
were performed using the protocol described in Figure 2.
As shown (Figure 6A-D), the treatment of the cells by
siOrai1 suppressed the BPA-induced SOCE amplification
by 60 to 80%. As described above, in the present study,
in order to eliminate the impact of steroids, and andro-
gens in particular, the experiments were performed in
CS-RPMI (−ST), a steroid-deprived medium. In this me-
dium, the expression of Orai1 was at least decreased by
90% (Flourakis et al. 2010). As expected, the siOrai1 treat-
ments of the cells without BPA treatments did not modify
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CaP cells. Following the 48 h BPA treatments, total proteins were
AGE), then transferred to PVDF membranes. Immuno-blots were then
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ell cultures and representative figures are presented. The fold variation
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Figure 6 Effect of Orai1 knockdown on Ca2+ entry induced by BPA treatments in LNCaP cells (A, B, C, D). Forty-eight hours prior to
recording Ca2+ signals by calcium imaging, LNCaP cells were divided into paired groups and transfected with control siRNA (siCTL), or siOrai1 in
the presence of 1 or 10 nM BPA. For Ca2+ recording, cells were treated with 200 nM thapsigargin (TG) in Ca2+-free bath solution
(0 Ca2+) and exposed to 2 mM extracellular Ca2+ (2 Ca2+) as indicated. Using the same protocol described above, pharmacological tools were
used to study the involvement of Orai1 in BPA-induced SOCE amplification. LNCaP cells were treated with BPA (1nM, 48h) and then the
TG-induced SOCE was studied in the presence or absence of BTP2 (2 μM) (E), an inhibitor of Orai1 or SKF96365 (10 μM) (F), a broad spectrum
inhibitor of ion channels involved in SOCE. Each experiment was repeated at least 3 times in duplicate in different cell cultures on a field of
25–40 cells and representative experiments performed on 50–80 cells as mean ± S.E. are presented. A quantification of the SOCE for each
experiment is presented in (B) and (D) (mean ± S.E.., n = 50–80 cells), *P < 0.001. The TG application is shown by an arrow and extracellular
Ca2+ increases from 0 (0 Ca2+) to 2 mM (2 Ca2+) are marked by horizontal bars.
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BPA 1 and 10 nM failed to inhibit the BPA-induced am-
plification of the calcium entry induced by TG (data not
shown).
Pharmacological tools were also used to study the in-
volvement of Orai1 in BPA-induced SOCE amplification.
LNCaP cells were treated with BPA (1nM, 48h) and then
the TG-induced SOCE was studied in the presence or ab-
sence of the inhibitors. When the experiments were per-
formed using a pyrazole derivative, BTP2 (2 μM), known
to inhibit calcium channels involved in SOCE including
Orai1 (Eltit et al. 2010), the TG-induced SOCE ampli-
tude in BPA-treated cells was inhibited by at least 40%
(Figure 6E). In the same manner, when the experiments
were performed in the presence of an inhibitor of store-
operated Ca2+ entry (SKF96365, 10 μM), the TG-induced
SOCE was almost completely inhibited in BPA-treated
cells (Figure 6F). Taken together, these data suggest that
the up-regulation of Orai1 is involved in the amplification
of the calcium entry induced by BPA.
Involvement of calcium entry in BPA-induced cell migration
We showed that Orai1 protein was up-regulated due to
BPA treatments of the LNCaP cells and that Orai1 was
involved in the amplification of the calcium entry into
these cells. To further investigate the correlation be-
tween Ca2+ influx, SOCE and cell migration induced by
BPA, we studied the effect of blocking Ca2+ influx on
LNCaP cell migration. Using a transwell migration assay,
we observed that when the cells were incubated in a
medium depleted in calcium by the addition of 1 mM
EGTA (Calcium chelating agent), thereby reducing the
extracellular free calcium to nominally 200 nM, the BPA
(10 nM)-induced migration of the LNCaP cells was com-
pletely inhibited (Figure 7A and B). In the same manner,
in order to study the involvement of SOCE in BPA-in-
duced migration, cells were treated with an inhibitor of
store-operated Ca2+ entry (SKF96365, 20 μM) in the pre-
sence of BPA (10 nM). As shown in Figures 7A and 7B,
SKF96365 blocked all BPA-induced cell migration. When
the experiments were performed using BTP2 (2 μM),
known to inhibit the calcium channel Orai1 involved in
SOCE (Figure 7B), the BPA-induced cell migration was
inhibited by 63 ± 11%. These pharmacological inhibitor
data show that blocking Ca2+ influx inhibits the BPA-
induced migration of LNCaP cells, and that the store-
operated Ca2+ entry channels including Orai1 are indeed
involved in the effects of BPA on cell migration.
BPA increases the migration of androgen-independent
prostate cancer cells
Previous studies reported by Wetherill et al. (2005) sho-
wed that low concentrations of BPA induced prolife-
ration in AR-dependent cells, but that the environmentalfactor failed to affect the growth of AR-negative, andro-
gen-independent PCa cell lines (PC-3 and DU-145). In the
present study, we examined the effects of BPA on the mi-
gration of the androgen-independent PCa cell line PC-3.
The cells were incubated for 48 h in CS-RPMI, both com-
plemented or not by BPA at different concentrations. The
cells were then wounded using a sterile tip and incubated
in the corresponding media for an additional 15 h before
microscopic examinations of the wound healing of the
cells. As shown in Figure 8A, these in vitro scratch tests of
PC-3 cells showed an increase in cell wound closure in re-
sponse to BPA, suggesting the induction of cell migration
by BPA in the androgen-independent PCa cell line PC-3.
In order to study the effects of BPA on Orai1 protein ex-
pression, Western blot experiments were performed on
total proteins of the PC-3 cells treated for 48 h with BPA
at varying concentrations. As shown in Figure 8B, BPA
induced a dose-dependent expression of Orai1 in PC-3
cells.
Discussion
It has been suggested that the environmental factor BPA
may play an important role in the initiation (Ho et al.
2006) and progression of PCa and in hormonal therapy
bypass (Wetherill et al. 2005). At the level of PCa cells,
BPA was able to induce androgen-independent tumor cell
proliferation and reduced therapeutic efficacy in xenograft
models (Wetherill et al. 2006). While these data point to-
ward the potential for BPA to assist tumor cells in esca-
ping therapy, the molecular mechanisms of this process
were not well-known.
This report demonstrates for the first time that the en-
vironmentally relevant concentrations of BPA (1–10 nM)
induce cell migration by modulating the cell calcium sig-
nalling. These data highlight the previously unrecognized
action of BPA in the progression of human PCa, thereby
providing strong support for the growing recognition of
the adverse effects of BPA on human health.
Invasion and metastasis are major events underlying
cancer morbidity and mortality (Molloy and Van ’t Veer
2008). Because of the widespread metastasis in advanced
cancer patients, where a resistance is observed to con-
ventional therapies, the mortality rate remains extremely
high and warrants new strategies to intervene in the me-
tastatic cascade. Thus, an enhanced understanding of
the molecular events in the pathogenesis of PCa will
offer improved diagnosis, prognosis, therapy and preven-
tion measures of the disease, that will ultimately help us
to eliminate PCa metastasis. A common regulatory point
in several signal transduction pathways is intracellular
calcium homeostasis. One approach could be to focus
on the intracellular signalling pathways underlying the
metastatic process. Several data have clearly shown the
involvement of calcium entry in cancer and non-cancer
CTL -ST
BPA 10 nM 
+ EGTA 1 mM



























Figure 7 BPA-induced SOCE is involved in prostate cancer cells migration. Cell migration was measured via the Transwell chamber assay.
(A) Following the 48 h 10 nM BPA treatment for, LNCaP cells were trypsinized and equal numbers of live cells were plated into inserts and
allowed to migrate for 24h in the presence or absence of BPA 10 nM, with or without the presence of a Ca2+ chelator EGTA (1 mM) or the SOCE
inhibitors (SKF, 20 μM; BTP-2, 2 μM). Cells in the insert (non-migrated cells) were then eliminated by scraping and migrated cells were fixed and
their nuclei were stained by Hoechst 33342 dye (Blue) and examined under fluorescence microscopy. At least ten different fields per condition
were examined and the cells counted. Experiments were performed in duplicate and repeated at least twice. (B) Relative migration (%) ± SE (Bar)
is shown for the control condition (CTL-ST), where the cells were incubated in CS-RPMI alone, and for BPA (10 nM) in the presence or absence of
the EGTA or SOCE inhibitors. *, P < 0.001 relative to CTL condition; ** P < 0.001 BPA 10 nM versus BPA 10 nM + inhibitors.
Derouiche et al. SpringerPlus 2013, 2:54 Page 10 of 16
http://www.springerplus.com/content/2/1/54cell migration (Bisaillon et al. 2010; Li et al. 2011; Schaff
et al. 2010; Yang et al. 2009).
In the present work, we present conclusive evidence
for the first time that the pre-treatment of human PCa
cells with environmentally relevant concentrations of BPA
(1–10 nM) induces their migration (Figure 1). By calcium
imaging technique, we show that BPA pre-treatment in-
duces an amplification of Store-Operated Calcium Entry
(SOCE) in LNCaP cells (Figure 2). RT-PCR and Western
blot experiments allowed us to identify those ion chan-
nel proteins up-regulated by BPA pre-treatments. Thesechannels include Orai1, a protein known to constitute an
important actor in SOCE in various cell systems including
human PCa cells (Figure 4). Meanwhile, in our studies, we
failed to observe any direct effect of BPA on the rate of
basal calcium (Figure 2) whereas in other cell systems,
BPA or its derivatives induced a calcium increase. In TM4
Sertoli cells, a direct application of a derivative compound
of BPA, Tetrabromobisphenol A (TBBPA), a commonly
used brominated flame retardant (BFR), induced an in-
crease in the basal free calcium rate originating from
internal stores (Ogunbayo et al. 2008). In pituitary tumor
1h
15h



























Figure 8 BPA induces the cell migration of androgen-independent prostate cancer cells. (A) Cell migration was studied via the in vitro
wound-healing assay. The PC-3 cells grown to confluent monolayers were incubated for 48 h in CS-RPMI, complemented or not by BPA at
different concentrations. The cells were then wounded using a sterile tip and incubated in the corresponding media for an additional 15 h before
the microscopic examinations of the wound-healing of the cells. Wound-healing was examined 1 and 15 hours after scratching, in at least 3
different previously identified (Blue line) fields per scratch and representative figures for each condition are presented here. (B) Western blot
analysis of whole cell lysate proteins of Orai1, in PC-3 cells treated with BPA at different concentrations. The figure is a representative experiment
showing the variation of Orai1 protein under BPA treatments. β-actin was used as a sample loading control. The fold variation of the Orai1
protein in different samples normalized to β-actin expression is shown under the panel. Results shown are representative of at least three
independent experiments.
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et al. (2009) showed that BPA at a 1 nM concentration
induced a great increase in Ca2+ oscillation frequency, the
activation of MAPK pathways (ERK1/2) and subsequently
a PRL release (Kochukov et al. 2009). Similar results
were reported by Bulayeva et al. (2005) and Wozniak
et al. (2005) where the authors demonstrated that the
BPA-induced Ca2+ influx was strictly dependent on
membrane Estrogen Receptor (mER-α) and mediated by
L-type voltage-gated Ca2+ channels in pancreatic β cells
(Bulayeva et al. 2005; Wozniak et al. 2005). The LNCaP
cells used in our present work do not express L-type
voltage-gated Ca2+channels (non-excitable cells). This is
probably the reason why a direct application of BPA on
LNCaP and LNCaP C4.2 cells failed to induce a direct
calcium response.
In the present work, when the human PCa cells were
pre-treated with BPA (1–10 nM), an increase in SOCEand a remodelling of ion channel expression was obser-
ved. The alterations of the ion channel expression could
be mediated by a stimulation of a signal transduction
pathways leading to the activation of nuclear transcrip-
tion factors. Published data suggest several transduction
pathways activated by BPA. In PCa cells, BPA has been
shown to be an agonist for mutant androgen receptor
(AR-T877A) expressed in recurrent PCa (Wetherill et al.
2002, 2005, 2006), and in the LNCaP cell line used in
our studies. According to the authors, BPA induces cell
proliferation in cells expressing the mutated AR. The
clinical ramifications of BPA activating tumor-derived
mutant ARs and inducing androgen-independent tumor
cell proliferation may be substantial, as BPA can reduce
therapeutic efficacy in xenograft models (Wetherill et al.
2006). In our experiments, the DHT induced the expres-
sion of Orai1 (Figure 4C) and BPA appears to mimic these
effects on the canonical AR ligand (DHT). However, all
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of AR. In a recent work, Hess-Wilson et al. (2007) showed
clearly that BPA and DHT elicited distinct transcrip-
tional signatures in PCa cells expressing the BPA-res-
ponsive mutant AR-T877A, even if some common genes
were activated by both DHT and BPA in LNCaP cells
(Hess-Wilson et al. 2007). These observations could ex-
plain the cell migration and Orai1 expression induced by
BPA in androgen-independent human PCa cells PC-3
(Figure 8), where the AR is absent. BPA could thus acti-
vate other signal transduction pathways than the AR acti-
vation, to induce the effects observed in our studies on
androgen-insensitive PCa cells. The study of the involve-
ment of other transduction pathways than those involving
the AR receptor (growth factor signalling pathways, . . .) in
the effects of BPA in androgen-dependent and androgen-
independent cells needs further extensive investigations in
the future. In this context, BPA was reported to induce
the phosphorylation of extracellular signal–regulated kin-
ase (ERK), c-Jun N-terminal kinase (JNK), and nuclear
translocation of the nuclear factor (NF)-κB, in mouse
hippocampal HT-22 cells (Lee et al. 2008). Interestingly,
functional NF-κB-binding sites in promoter regions of
STIM1 and Orai1 have been identified and the expression
of the Orai1 calcium channel was reported to be po-
sitively modulated by NF-κB (Eylenstein et al. 2012).
Subsequently, the store-operated Ca2+ entry was simi-
larly increased by overexpression of p65/p50 or p65/
p52, and decreased by treatment with the NF-κB inhibitor,
Wogonin. BPA could thus interfere with the growth fac-
tors' signal transduction to activate the PI3K/AkT pathway
and thereby induce the activation of the NF-kB transcrip-
tion factor, leading in turn to an up-regulation of the ex-
pression of ion channels including Orai1. In this context,
authors have shown that the activation of mER-α in-
duces the activation of the PI3K/Akt signalling cas-
cade (Simoncini et al. 2003; Stirone et al. 2005) and BPA
is shown to activate mER-α (Bouskine et al. 2009; Quesada
et al. 2002). The activation of the mER-α in androgen-
dependent (LNCaP) and androgen-independent (PC-3)
PCa cells may thus induce the PI3K/Akt signalling cascade
which leads to the activation of the NF-kB transcription
factor and Orai1 gene expression. Several works have also
demonstrated the stimulation of the PKA/CREB pathways
by nanomolar concentrations of BPA through the activa-
tion of mER-α (Bouskine et al. 2009; Quesada et al. 2002).
However, the involvement of this pathway in the expres-
sion of ion channels needs further investigation. As shown
in Figure 5, BPA pre-treatment induced an increase in
BKCa and IKCa1 Ca
2+-activated potassium channel ex-
pression in LNCaP cells. We previously showed that
the IKCa1 Ca
2+-activated potassium channels are invol-
ved in SOCE in LNCaP and PC-3 human PCa cells
(Lallet-Daher et al. 2009). These potassium channelscould constitute a functional complex with Orai1 protein
to promote calcium entry and cell migration. A study is in
progress in our lab to show the functional up-regulation
and involvement of these Ca2+-activated potassium chan-
nels (IKCa1 and BKCa) in cell migration in the BPA-treated
LNCaP and PC-3 cancer cells.
Receptor-mediated activation of phospholipases C by
the factors present in the serum leads to IP3-mediated
depletion of Ca2+ from the ER, which in turn stimu-
lates Ca2+ influx through the plasma membrane involv-
ing Orai1/STIM1 complex formation (Varnai et al. 2009).
Recent works have elegantly demonstrated that STIM1,
Orai1, and SOCE play critical roles in the migration of
a number of cell types in cancer and non-cancer cells
(Bisaillon et al. 2010; Li et al. 2011). These observations
support our data where BPA, by up-regulating the ion
channels expression increases the SOCE developed by
PCa cells in response to factors present in serum.
Our data show clearly that the BPA-induced cell mi-
gration is dependent on the calcium entry and the use
of pharmacological tools suggests the involvement of
SOCE channels in the effects of BPA on cell migration
(Figure 7). Increase in cytoplasmic calcium induced by
BPA may have several types of impacts which trigger cell
migration, including the induction of the up-regulation
of their gene and protein expression, secretion and the
activation of the enzymes such as metalloproteinases
(MMP2, MMP9), which are involved in cell migration.
The MMP proteins are clearly shown to be dependent
on calcium for their expression (calcium/Calcineurin/
NFAT, . . .), their processing and their activity (Collier
et al. 1988; Mukhopadhyay et al. 2004; Stetler-Stevenson
et al. 1989). These observations suggest that the increase
in calcium entry induced by BPA pre-treatment could pro-
mote all these processes leading to cell migration.
For the first time, we also demonstrate the expression
of Orai1 proteins in human PCa tissues (Figure 4F). As
shown, a strong immuno-staining of Orai1 protein was
found in epithelial cells of the acini and also in the
stromal cells. Thus, stromal cells could also be influen-
ced by BPA impregnation. Given the importance of the
epithelium-stroma (reactive stroma) in the progression
of cancer, the potential effects of BPA on calcium signal-
ling and on the secretion of growth factors by these cells
need further investigation.
Conclusions
BPA is consistently detected in almost all individuals
in developed nations (Welshons et al. 2006), suggesting
that humans are continuously exposed to BPA. In ad-
dition, the rapid metabolic clearance of BPA and its de-
tectable levels in human blood and urine suggest that
the intake of BPA may be higher than indicated by di-
verse studies and that long-term daily intake may lead to
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health and on cancer progression.
These observations suggest that the BPA concentra-
tions used in the present study are attainable in humans.
The present data provide novel insights into the way in
which the molecular mechanisms involved in the effects
of environmental factors can promote the progression
of the cancer in an androgen-independent manner. Our
work also highlights the urgency of taking preventive
measures and suggests some potential therapeutic op-
portunities of targeting the ion channels involved in




Bisphenol A (BPA) was obtained from Sigma-Aldrich
and dissolved in DMSO. Antibodies raised against hu-
man ion channel proteins were obtained from commer-
cial sources as follows: Rabbit anti-Orai1 (ProSci Inc.),
Rabbit anti-STIM1 (ProSci Inc.), Rabbit anti-TRPC1
(Alomone Labs), Rabbit anti-TRPV6 (Santa Cruz Biotech-
nology) and Rabbit anti-β-actin (Santa Cruz Biotech-
nology) and horseradish peroxidase-conjugated secondary
antibodies (Santa Cruz Biotechnology).
Cell culture
LNCaP, LNCaP-C4.2 and PC-3 PCa cell lines, obtained
from the American Type Culture Collection (ATCC,
Manassas, VA, USA), were cultured in RPMI 1640 and
serum as described by Gackière et al. (Gackiere et al.
2006). For BPA experiments, the cells were treated with
Phenol red-free RPMI 1640 containing charcoal-stripped
Foetal Calf Serum (FCS) (CS-RPMI). In order to avoid
the interference between BPA added for our studies and
those leached from RPMI 1640 commercialized in po-
lycarbonate bottles, the medium was prepared in glass
bottles using RPMI 1640 powder commercialized by
SIGMA (L’Isle d’Abeau, France) in ultrapure water and
then filtered on 0.2 μm filters (Thermo Scientific Nalgene,
Fontenay-sous-Bois France).
RT–PCR analysis of mRNA expression
Total RNA isolation and RT-PCR experiments were
performed as described earlier (Roudbaraki et al. 1999).
The PCR primers (Orai1: 5’-CTTCTTCGACCTCGTC
CTCCT-3’ and 5’-CGTAAGGCCAAAGCATGGAA-3’;
β-actin : 5’-CAGAGCAAGAGAGGCATCCT-3’ and 5’-
GTTGAAGGTCTCAAACATGATC-3’ used in this stu-
dy were designed on the basis of established GenBank
sequences and synthesized by Invitrogen (Carlsbad, CA,
USA). The amplified PCR products were of 406 and 212
bp respectively.siRNA transfections
For siRNA experiments, equal numbers of cells from
the same culture were seeded, transfected overnight with
20 nM of control siRNA (targeting Luciferase mRNA)
(Eurogentec, Belgium), or raised against Orai1 mRNA
(siOrai1) (50-UGAGCAACGUGCACAAUCU (dTdT)-30),
using Hyperfect transfection reagent (Qiagen Inc.,
Courtaboeuf, France) in CS-RPMI containing 10% SVF,
according to the manufacturer's instructions. Medium was
changed after 24 h and cells were incubated for a further
48h with or without BPA, before performing calcium im-
aging experiments. We previously showed the efficiency of
the siOrai1 used in the present study, in down-regulating
the expression of the Orai1 protein in LNCaP cells
(Flourakis et al. 2010).Orai1 immunofluorescence studies
The protein expression studies of the ion channels in
PCa cells were determined by indirect immunofluore-
cence analysis performed on acetone-fixed cells. Cells
grown on glass cloverslips were incubated with PBS con-
taining 0.2% BSA, 0.1% TritonX-100 and 5% donkey
serum, for 30 min at room temperature, in order to
block the non-specific bindings and to permeabilize the
cells. They were then incubated overnight at 4°C with
PBS/5% non-immunized serum containing a 1:50e dilu-
tion of the primary affinity-purified rabbit anti-Orai1
polyclonal antibody. Cells were then washed with PBS
and were incubated with the secondary Alexa fluor
488-labeled anti-rabbit IgG (A-21206; Molecular Probes;
dilution 1:2000e) diluted in PBS for 1 h at room
temperature. After rinsing three times in PBS, the slides
were mounted with Mowiol and the distribution of the
labelled proteins was analysed by confocal immunofluo-
resccence microscopy (Zeiss LSM 510; acquisition parame-
ters: objective 40x/1.3; thickness of confocal slide, 1 μm).
For the immunofluorescence studies of Orai1 protein
in human PCa, tissues were obtained from consenting
patients following local ethical considerations. The tis-
sues were diagnosed as cancerous or not by anatomo-
pathological examinations. Tissues were from patients
prior to any anticancer therapy (chemotherapy, radio-
therapy) and were obtained following an office proce-
dure, frozen in liquid nitrogen-cooled isopentane and
kept in “Tissue-TekW” at −80°C before 10 μm cryo-
sections were carried out at −20°C with a cryostat and
mounted on glass slides for immunofluorescence studies.
All experiments involving patient tissues were carried
out under approval number “CP 01/33”, issued by the
“Comité Consultatif de Protection des Personnes dans la
Recherche. The immunofluorescence experiments for
the detection of Orai1 on 7 μm cryosections was carried
out following the same procedure as for the PCa cell
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focal microscopy.
Western blot assay
Cells cultured at 80% confluence were harvested and
total proteins extracted. 40 micrograms of each sample
were analysed by SDS-PAGE on 10% acrylamide and
processed for western-blotting using antibody as descri-
bed by (Vanoverberghe et al. 2004) using BKca (Alomone,
1:500e), TRPV6 (Alomone, 1:500e), TRPC1 (Alomone,
1:500e), Orai1 (ProSci 1:500e), STIM1 (ProSci, 1:500e),
IKCa1 (Santa Cruz, 1:200e). Western blotting was perfor-
med with an ECL chemiluminescence kit (Millipore).
Quantitative evaluation of protein expression was perfor-
med using ImageJ software.
[Ca2+]i measurements
Cells were grown on glass coverslips for [Ca2+]i imaging
experiments and, before each experiment, the cells were
loaded with Fura-2, by adding 2 μM Fura-2 AM (Fura-2
Acetoxymethyl esther) (Calbiochem, Meudon, France) to
the culture medium for 45 min at 37°C. The cells cells
were then washed three times in HBSS (Hanks Balanced
Salt Solution; 142 mM NaCl, 5.6 mM KCl, 1 mM MgCl2,
2 mM CaCl2, 340 μM Na2PO4, 440 μM KH2PO4, 10
mM Hepes, 5.6 mM glucose and buffered to pH 7.4).
When a Ca2+-free medium was required, CaCl2 was
omitted and replaced by equimolar MgCl2. The fluores-
cent intensity of Fura-2 in each cell was monitored and
recorded at 340 and 380 nm. To represent the variation
in the intracellular free calcium concentration, either the
fluorescence intensity ratio represented by F340/F380
was used as an indicator of changes in cytosolic Ca2+
concentrations, or a calibration was used to represent
such variations in nM. All measurements shown are ave-
rages of 35–45 cells from a minimum of four experi-
ments on different cell cultures.
Cell migration assays
Cell migration assays were performed in duplicate in
modified Boyden chambers. These assays consisted in
counting cells migrating through a porous membrane
with 8 μm pores (BD Biosciences, Oxford Science Park,
Oxford, UK). After trypsinisation, cells in suspension
(1 × 105) were loaded into the upper chamber in phenol-
red RPMI without FCS. The lower chamber contained
RPMI and 10% charcoal-stripped (CS)-FCS (CS-RPMI).
The upper and lower chambers contained the same con-
centration of BPA when tested. After 16 h to 24 h at
37°C in a 5% CO2 incubator, cells that had attached but
not migrated were scraped from the upper surface, the
membranes were fixed in 70% methanol at −20°C and
the migrated cells were stained for nuclei with Hoechst
33342 dye (1 μg/mL) (blue fluorescent) and evaluated bycounting cell nuclei in 10 randomly chosen fields under
fluorescence microscopy. The results are presented as a
percentage of control (CTL), where cells were incuba-
ted in CS-RPMI culture medium alone. Alternatively,
the Wound Healing Assay was also used to study PCa
cell migration. The cells were seeded in a 12-well plate
(15 × 104). After the cells formed a confluent mono-layer,
scratches were performed using a 100 μl tip. The wells
were washed with PBS followed by the addition of BPA
at different concentrations in CS-RPMI. The closure of
scratch was analyzed under the microscope and images
were captured 1 and 15 or 24 h after incubation in the
presence or absence of BPA.
Statistical analysis
Plots were produced using Origin 5.0 (Microcal Soft-
ware, Inc., Northampton, MA). Results are expressed
as mean ± S.E. Statistical analysis was performed using
unpaired t tests or ANOVA tests followed by either
Dunnett (for multiple control versus test comparisons), or
Student-Newman-Keuls post-tests (for multiple compa-
risons). The Student’s t-test was used for statistical com-
parison of the differences and p < 0.05 was considered
significant.
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